CN108703362A - A kind of nourishing ovary health care tabletting and preparation method thereof - Google Patents
A kind of nourishing ovary health care tabletting and preparation method thereof Download PDFInfo
- Publication number
- CN108703362A CN108703362A CN201810396582.8A CN201810396582A CN108703362A CN 108703362 A CN108703362 A CN 108703362A CN 201810396582 A CN201810396582 A CN 201810396582A CN 108703362 A CN108703362 A CN 108703362A
- Authority
- CN
- China
- Prior art keywords
- tabletting
- health care
- parts
- ovary
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 66
- 210000001672 ovary Anatomy 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 241000208340 Araliaceae Species 0.000 claims abstract description 24
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 24
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 24
- 235000008434 ginseng Nutrition 0.000 claims abstract description 24
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 22
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 22
- 241001328788 Camellia nitidissima Species 0.000 claims abstract description 18
- 230000000694 effects Effects 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims description 18
- 229920002472 Starch Polymers 0.000 claims description 16
- 238000000227 grinding Methods 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 8
- 239000005556 hormone Substances 0.000 abstract description 3
- 229940088597 hormone Drugs 0.000 abstract description 3
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 210000000952 spleen Anatomy 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 13
- 235000019890 Amylum Nutrition 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000003304 gavage Methods 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000002611 ovarian Effects 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 239000000262 estrogen Substances 0.000 description 5
- 229940011871 estrogen Drugs 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000005374 Poisoning Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000027758 ovulation cycle Effects 0.000 description 3
- 210000004681 ovum Anatomy 0.000 description 3
- 231100000572 poisoning Toxicity 0.000 description 3
- 230000000607 poisoning effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001550 testis Anatomy 0.000 description 3
- 241000213006 Angelica dahurica Species 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010051131 Mastoptosis Diseases 0.000 description 2
- 241001122767 Theaceae Species 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000001794 hormone therapy Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010049976 Impatience Diseases 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000003914 endometrial carcinoma Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000006101 laboratory sample Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000021180 meal component Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 201000005111 ocular hyperemia Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 210000002394 ovarian follicle Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 206010036601 premature menopause Diseases 0.000 description 1
- 208000017942 premature ovarian failure 1 Diseases 0.000 description 1
- 230000001072 progestational effect Effects 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 102000014898 transaminase activity proteins Human genes 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pregnancy & Childbirth (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
Abstract
The present invention provides a kind of nourishing ovary health care tabletting, it includes active component and pharmaceutically acceptable auxiliary material, and the active component includes pollen pini, ginseng, Camellia nitidissima, Radix Notoginseng and Radix Angelicae Sinensis.It is pure Chinese medicine product that the ovary, which nourishes health care tabletting, is free of hormone, is free from side effects.The present invention also provides the preparation methods that the ovary nourishes health care tabletting, and this method is simple, easy to operate, and process costs are low, are suitable for large-scale production.
Description
Technical field
The invention belongs to field of health care products, and in particular, to a kind of nourishing ovary health care tabletting and preparation method thereof.
Background technology
Ovary is one of most important organ of human body women, is the place for storing egg mother cell, and ovary state directly determines
Female fertility.Ovum in ovary is with the primary of static primordial follicle or growth conditions, the shape of secondary follicle
Formula exists.Ovarian function failure, suspend mode ovarian follicle, which cannot activate, to be reentered growth phase and can cause to lose fecundity, and ovary is early
It declines while also influencing ovarian secretion progestational hormone, estrogen can also directly result in the aging of woman to influence sexual function.It is external
Menopausal women is set to restore physiological period again after the ovarian transplantation for having had research youth now, it is seen that the function of ovary is for female
The body and younger state of people has very big relationship.
Not ovulated caused by premature ovarian failure with not ovulating caused by other unknown causes has common characteristic, unexcellent
Gesture follicle maturity and discharge, without official holiday.These affect the fecundity of the women of child-bearing age, bring prodigious psychology negative to them
Load, affects the physical and mental health of women.There are many factor for causing ovarian function impaired, and excessive weight-reducing, stress be excessive, no
Good living habit all may cause harmful effect to the health of ovary.
But the impaired treatment with menstrual disorder of ovarian function is extremely difficult, up to the present, still without clear effective
Remedy measures restore or protection ovarian function.Currently, the main method for the treatment of is by doctor trained in Western medicine hormone therapy, patient often needs few
The estrogen or Estrogen and progestin cycle therapy of amount.The method of this hormone therapy only makes women restore just on hormonal readiness
Often, can surface eliminate menopausal syndrome, there is no impaired ovary is really repaired, majority are easily recurred after drug withdrawal, and only
Accomplish that this point is also required to women and pays a high price for, American Women health association (Wommen ' s Health
Lnitiative, WHI) clinical research discovery, hormone replacement therapy (HRT) is although reduce the danger of osteoporosis and fracture
Property；But increase breast cancer, carcinoma of endometrium and cardiovascular disease, apoplexy incidence.
In order to carry out ovary maintaining, a series of massage manipulations, corresponding essential oil and ovary maintaining drug are developed to ovum
Nest is maintained, and still, normal ovarian is located at pelvis depths and only fist size, and usually massage is difficult to influence ovary, into
And corresponding essential oil can not also be made to play the effect for nourishing ovary, meanwhile, there is no medicine to carry on the back for most of refined-oil development and user
Scape often the effect to various essential oils and its compatibility relationship and is not known about, and there are difficulty, effect can not also protect for the use of essential oil
Barrier；And existing ovary health medicine contains estrogen mostly, long-term use easily causes more gynecological diseases, and there are larger
Risk, therefore, exploitation is a kind of to have important reality meaning without estrogen, the health products be free from side effects, can nourish ovary
Justice.
Invention content
In view of this, a kind of nourishing ovary health care tabletting of present invention offer and preparation method thereof, to solve the above problems.
Specifically, the present invention adopts the following technical scheme that：
A kind of nourishing ovary health care tabletting, it includes active component and pharmaceutically acceptable auxiliary material, the active component
Including pollen pini, ginseng, Camellia nitidissima, Radix Notoginseng and Radix Angelicae Sinensis.
Based on above-mentioned, in terms of mass fraction, the active component includes 14~18 parts of pollen pini, 3~7 parts of ginseng, golden flower
19~25 parts of 22~45 parts of tea, 21~33 parts of Radix Notoginseng and Radix Angelicae Sinensis.
Based on above-mentioned, in terms of mass fraction, the active component include 15 parts of pollen pini, 4 parts of ginseng, 31 parts of Camellia nitidissima,
23 parts of 27 parts of Radix Notoginseng and Radix Angelicae Sinensis.
Pollen pini：It is sweet in flavor, it is warm-natured, it is nontoxic；Return liver, the spleen channel；Benefit spleen sweet in flavor, moistening lung qi-benefitting；It dissipates liver and removes wind；Stop blooding with spleen.
Radix Angelicae Sinensis：It is sweet in flavor, pungent, it is warm-natured；Return liver, the heart, the spleen channel；It enriches blood；Promoting blood circulation；Menstruction regulating and pain relieving；Moisturize laxation.
Radix Notoginseng：Sweet in flavor, slight bitter, it is warm-natured；Return liver, stomach, the heart, lung, large intestine channel；Removing blood stasis and hemostasis, analgesic therapy of invigorating blood circulation.
Camellia nitidissima：It is mildly bitter flavor, puckery, it is mild-natured；Return liver and kidney channel；It is clearing heat and detoxicating, inducing diuresis to remove edema, stop dysentery.
Ginseng：Sweet in flavor, slight bitter, it is mild-natured；Returns spleen, lung, the heart channel of Hang-Shaoyin；It reinforces vital energy, veins takes off admittedly reinforces the spleen to benefit the lung, and promotes the production of body fluid, peace
God.
Based on above-mentioned, the auxiliary material includes honey, amylum pregelatinisatum and sodium carboxymethyl starch.
A kind of preparation method of above-mentioned nourishing ovary health care tabletting its include the following steps：
The sundries in each raw material in the active component is rejected in pretreatment, featured, cleaning, drying, dry to containing
Water rate≤3% is spare；
Coarse crushing will be crushed with Roughpulverizer respectively by pretreated each raw material, and it is spare to cross 80~140 mesh sieve；
Each raw material after coarse crushing is obtained the micropowders of each raw material by ultramicro grinding through ultramicro grinding respectively；
Mixture granulation is uniform by the micropowders mixture of each raw material, the auxiliary material is then added, and pelletized, done successively
Dry, compressing tablet process, you can be made and nourish ovary health care tabletting.
Based on above-mentioned, the granularity of the micropowders is 800~900 mesh.
Compared with prior art, the present invention has substantive distinguishing features outstanding and marked improvement.Specifically, the present invention carries
The active component that the ovary of confession nourishes health care tabletting includes pollen pini, ginseng, Camellia nitidissima, Radix Notoginseng and Radix Angelicae Sinensis, and five kinds of Chinese medicines are mutual
It is bonded an indivisible entirety, the scorching of pollen pini, ginseng and Radix Notoginseng is alleviated by Camellia nitidissima, ginseng can be mended greatly
Vigour makes Radix Notoginseng give full play to its effect, and ginseng and pollen pini also have effects that strengthening the spleen and replenishing qi to promote Chinese angelica blood supplementing to live
Blood, menstruction regulating and pain relieving；In addition, destroying in overy root in kidney, hair in liver, control in spleen, ovary provided by the invention nourishes health care tabletting tool
There is foster kidney, dredge the effect of strongly fragrant, beneficial spleen, achievees the effect that ovary nourishes from the angle of kidney,liver,spleen；Meanwhile the ovary nourishes
Health care tabletting is pure Chinese medicine product, is free of hormone, is free from side effects.
The present invention also provides the preparation methods that the ovary nourishes health care tabletting, and this method is simple, easy to operate, process costs
It is low, it is suitable for large-scale production.
Specific implementation mode
Below by specific implementation mode, technical scheme of the present invention will be described in further detail.
Embodiment 1
The present embodiment provides a kind of ovaries to nourish health care tabletting, it includes the raw material of following mass parts：14 parts of pollen pini, people
12 parts of 3 parts of ginseng, 22 parts of Camellia nitidissima, 21 parts of Radix Notoginseng, 19 parts of Radix Angelicae Sinensis, 3 parts of honey, 9 parts of amylum pregelatinisatum and sodium carboxymethyl starch.
A kind of ovary nourishes the preparation method of health care tabletting comprising following steps：
The sundries in pollen pini, ginseng, Camellia nitidissima, Radix Notoginseng, Radix Angelicae Sinensis raw material is rejected in pretreatment, featured, clean, dry in the air
It shines, is dry spare to moisture content≤3%；
Coarse crushing will be crushed with Roughpulverizer respectively by pretreated each raw material, and it is spare to cross 80~140 mesh sieve；
It is each raw material of 800~900 mesh that each raw material after coarse crushing is obtained granularity by ultramicro grinding through ultramicro grinding respectively
Micropowders；
Mixture granulation is uniform by the micropowders mixture of each raw material, and honey, amylum pregelatinisatum and carboxymethyl is then added and forms sediment
Powder sodium is uniformly mixed, and is pelletized, dried successively, compressing tablet process, you can is made and is nourished ovary health care tabletting, the nourishing ovum
The piece weight of nest health care tabletting is 0.1g.
Embodiment 2
The present embodiment provides a kind of ovaries to nourish health care tabletting, it is made of the raw material of following mass parts：18 parts of pollen pini,
23 parts of ginseng part, 45 parts of Camellia nitidissima, 33 parts of Radix Notoginseng, 25 parts of Radix Angelicae Sinensis, 8 parts of honey, 14 parts of amylum pregelatinisatum and sodium carboxymethyl starch.
The preparation method that the ovary nourishes health care tabletting is same as Example 1.
Embodiment 3
The present embodiment provides a kind of ovaries to nourish health care tabletting, it includes the raw material of following mass parts：15 parts of pollen pini, people
15 parts of 4 parts of ginseng, 31 parts of Camellia nitidissima, 27 parts of Radix Notoginseng, 23 parts of Radix Angelicae Sinensis, 5 parts of honey, 12 parts of amylum pregelatinisatum and sodium carboxymethyl starch.
The preparation method that the ovary nourishes health care tabletting is same as Example 1.
The security performance and clinical efficacy of health care tabletting are nourished by ovary described in following experimental verification：
One, animal experiment-research ovary nourishes the safety of health care tabletting
1, studies on acute toxicity
Mouse 20, half male and half female, the ovary that gavage gives the embodiment of the present invention 1~3 is taken to nourish health care tabletting, specifically
For：It respectively takes 50g crushing plus distilled water to 100ml ovary nourishing health care tabletting, 4 hours oral gavages is spaced in one day to mouse
2 times, each gavage volume is 0.2ml/10gbw, intergal dose 20.00g/kgbw.Fasting 16 hours before gavage for the first time,
It is observed continuously after gavage two weeks, records poisoning manifestations and death condition.The result shows that gavage ovary of the present invention nourishes health care tabletting
Two kinds of genders intragastric administration on mice after have no apparent poisoning symptom, observation 14 days is without death.The observation end of term puts to death animal subject
Dissection inspection is carried out, the main organs such as liver,spleen,kidney, stomach, intestines, the heart, lung show no obvious abnormalities change.The health care tabletting of the present invention
The maximum tolerated dose (MTD) of female to Kunming kind, male mouse is more than 20.00g/kgbw, according to《Health food is examined and evaluation
Technical specification》Acute toxicity grading criteria in (version in 2003), belongs to nontoxic grade.
2, long-term to feed research
Take SD rats 80, experimental animal is randomly divided into four groups by half male and half female, i.e. control group and three tested group, often
Group 20, half male and half female.If the basic, normal, high dosage of sample is respectively 0.825g/kgbw, 1.650g/kgbw, 3.300g/
Kgbw is respectively equivalent to 25,50,100 times of human body recommended dose.Basic, normal, high dose of test liquid takes this hair respectively when preparing
The ovary of bright Examples 1 to 3 nourishes health care tabletting each 8.25g, 16.50g, 33.00g and distilled water is added to be settled to 100ml, control group
Give isometric distilled water, daily gavage is primary, gavage volume be 1.0ml/100gbw, continuous 30 days.During 30 days feed,
Each group animal growth is good, behavior without exception and poisoning symptom, no death, during nursing；When each dosage group male and female mouse is each
Point weight, end weight and weightening, weekly and total food-intake, weekly and total food utilization rate no significant difference compared with the control group；
The hemoglobin of each dosage group male and female rat, Erythrocytes, packed cell volume, platelet count, total white blood cells and classification with
Control group compares, no significant difference P > 0.05)；The total protein of each dosage group male and female rat, albumin, glutamic-pyruvic transaminase, paddy
Careless transaminase, cholesterol, triglycerides, urea nitrogen, creatinine, blood glucose there are no significant compared with the control group difference；Each dosage group
Weight and liver, kidney, spleen, the absolute weight of testis and liver/body, spleen/body, kidney/body, male mouse after the last fasting of the experiment of rat
Testis/body ratio compared with the control group, no significant difference；After carrying out gross anatomy, the liver of female, the great and mighty or powerful mouse of high dose group, spleen,
Kidney, stomach, intestines, testis (ovary) are showed no obviously Histopathologic changes related with experimental factor.
Two, ovary of the present invention nourishes the safety human feeding trial of health care tabletting
1, process is tested
Prepare 1, No. 2 by test product, the two is almost the same in packaging, appearance, color and luster and mouthfeel, one of them is the present invention
Examples 1 to 3 any health care tabletting, another is placebo；
Selected subject's male or female, 18~65 years old age, physical condition is good, without apparent brain, the heart, liver,
Lung, kidney, blood sufferer, without Long-term taking medicine history.
Test-meal group and control group are randomly divided into subject, consider the principal element such as age, the property that influence result as far as possible
Not, Diet lifestyle etc. carries out harmonious inspection, and with the comparativity between guarantee group, test-meal experiment is carried out by double-blind study.
Using itself between group two kinds of control designs.Subject is randomly divided into test-meal group and control by aforementioned groupings design
Group, test group are taken by everyone twice daily, 3 tablets each time by test product, and control group takes placebo, continuous 180 days.During experiment
The life of control group and test-meal group, eating habit are constant.
The indices to be detected on-test and at the end of respectively detect 1 time.
2, safety detection
Ordinary circumstance：
Initial trial crowd test-meal group 52, control group 52, before and after test-meal, subject's spirit, sleep, diet, size
Just situation no abnormality seen.Control group：Male/female is 19/34, and the age is 55.57 ± 5.10 years old；Test-meal group：Male/female is 19/34, year
Age is 55.74 ± 5.12 years old.
Safety observations：
It eats after by test product 180 days, test-meal group and control group weight, blood pressure, heart rate are showed no obvious abnormalities change, and blood is normal
Rule, routine urinalysis, stool routine examination and biochemical indicator in normal range (NR), this illustrate the present invention health care tabletting to body health without
Apparent damage.
Simultaneously electrocardiogram, abdominal B-scan ultrasonography, Chest X-rays inspection, be showed no obvious abnormalities.Have no relevant not with sample during test-meal
Good reaction.
Three, ovary of the present invention nourishes the women test-meal experiment of health care tabletting
1. Zhang, 35 years old, pachylosis, had microgroove at dimness；Mastoptosis, atrophy；Menstrual cycle is irregular；Take this
After the health care tabletting 90 days of inventive embodiments 1, skin becomes smooth, fine and smooth, it is flexible to compact；Mastoptosis atrophy is also changed
Kind, the menstrual cycle tends to be normal.
2. money, 28 years old, skin pore was coarse, matt, cheek has blackening, paramenia；Take the embodiment of the present invention 2
Health care tabletting 90 days after, skin becomes careful, and the color spot on cheek is thin out, and menstruation recovery is normal.
2. Wu, 25 years old, insomnia and dreamful sleep；Stress is big；Dysmenorrhoea；Take the health care tabletting of the embodiment of the present invention 3 90 days
Afterwards, mood Shu Lang, dysmenorrhoea phenomenon are alleviated.
3. week certain, 50 years old, there is age spot to body in cutis laxa, many places everywhere；Menopause symptom is apparent, irascible uneasy；
After the health care tabletting 180 days for taking the embodiment of the present invention 3, skin becomes to compact, and the age spot on cheek is thin out, and impatience obtains
To alleviate, sleep is good.
4. Chen 34 years old, there is microgroove on the face, face is obscure, turns to be yellow, and menstrual period shorten；Take the health care of the embodiment of the present invention 2
After tabletting 180 days, microgroove disappears on the face, and face is shinny, and menstruation recovery is normal.
Four, Radix Angelicae Sinensis, pollen pini, Radix Notoginseng, ginseng and Camellia nitidissima single factor test test-meal experiment
Subject：
240 people of subject, is the women at 18~65 years old age, physical condition is good, without apparent brain, the heart, liver, lung,
Kidney, blood sufferer, without Long-term taking medicine history, temper is gentle, subject is normally randomly divided into 10 groups of (control group 1~5 and examinations by complexion
Food group 1~5), every group of 20 people, men and women is fifty-fifty.The life of control group and test-meal group, eating habit are constant during experiment.
Laboratory sample：
Test-meal group 1~5：The health care tabletting of the embodiment of the present invention 3；
Control group 1：The embodiment of the present invention 3 removes the health care tabletting that Radix Angelicae Sinensis ingredient obtains.(Radix Angelicae Sinensis is by amylum pregelatinisatum generation
For)
Control group 2：The embodiment of the present invention 3 removes the health care tabletting that preserved egg meal component obtains.(pollen pini is by amylum pregelatinisatum
Instead of)
Control group 3：The embodiment of the present invention 3 removes the health care tabletting that Radix Notoginseng ingredient obtains.(Radix Notoginseng is by amylum pregelatinisatum generation
For)
Control group 4：The embodiment of the present invention 3 removes the health care tabletting that constituent of ginseng obtains.(ginseng is by amylum pregelatinisatum generation
For)
Control group 5：The embodiment of the present invention 3 removes the health care tabletting that golden flower tea components obtain.(Camellia nitidissima is by amylum pregelatinisatum
Instead of)
Experimental method：
Test-meal group is by the health care tabletting for taking the embodiment of the present invention 32 times a day, 3 tablets each time；Control group 1 by 2 times a day,
Take the health care tabletting without Radix Angelicae Sinensis of the embodiment of the present invention 3 respectively 3 tablets each time；Control group 2 by distinguishing 2 times a day, 3 tablets each time
Take the health care tabletting without pollen pini of the embodiment of the present invention 3；Control group 3 by 2 times a day, take this hair respectively 3 tablets each time
The health care tabletting without Radix Notoginseng of bright embodiment 3；Control group 4 by 2 times a day, take the embodiment of the present invention 3 respectively 3 tablets each time
Health care tabletting without ginseng；Control group 5 by take respectively 2 times a day, 3 tablets each time the embodiment of the present invention 3 be free of Camellia nitidissima
Health care tabletting；Experimental period is 30 days, observes test-meal group and control group daily, and subject flushing constipation occurs and urinates red, dry throat eye
Red, red tongue body tongue fur is yellow, dry mouth with bitter taste, and arteries and veins more counts；It is physically weak to be taken off, cold weak pulse of limb；Loose stool；Any exceptions such as taste imbalance
Situation stops experiment, and experimental result is referring to table 1.
1 Radix Angelicae Sinensis of table, pollen pini, Radix Notoginseng, ginseng and Camellia nitidissima single factor test test-meal experiment
It is safe and non-toxic by testing the health care tabletting it is found that the present invention above, it is suitable for clinical application；And the health care pressure
Five kinds of Chinese medicines, which be combined with each other, in piece constitutes an indivisible entirety, alleviates pollen pini, ginseng and Radix Notoginseng by Camellia nitidissima
Scorching, ginseng, which can reinforce vital energy, makes Radix Notoginseng give full play to its effect, and ginseng and the pollen pini also work(with strengthening the spleen and replenishing qi
Effect is to promote Chinese angelica blood supplementing to invigorate blood circulation, menstruction regulating and pain relieving；In addition, destroying in overy root in kidney, hair in liver, control in spleen, it is provided by the invention
Ovary, which nourishes health care tabletting, to be had foster kidney, dredges the effect of strongly fragrant, beneficial spleen, is carried out ovary nourishing from the angle of kidney,liver,spleen, is reached
To adjust the menstrual cycle, beautifying face and moistering lotion, alleviate climacteric syndrome the effect of.
Finally it should be noted that：The above embodiments are merely illustrative of the technical scheme of the present invention and are not intended to be limiting thereof；To the greatest extent
The present invention is described in detail with reference to preferred embodiments for pipe, those of ordinary skills in the art should understand that：Still
It can modify to the specific implementation mode of the present invention or equivalent replacement is carried out to some technical characteristics；Without departing from this hair
The spirit of bright technical solution should all cover within the scope of the technical scheme claimed by the invention.
Claims (6)
1. a kind of nourishing ovary health care tabletting, it includes active component and pharmaceutically acceptable auxiliary material, which is characterized in that described
Active component includes pollen pini, ginseng, Camellia nitidissima, Radix Notoginseng and Radix Angelicae Sinensis.
2. nourishing ovary health care tabletting according to claim 1, which is characterized in that in terms of mass fraction, the activearm
It includes 19~25 parts of 14~18 parts of pollen pini, 3~7 parts of ginseng, 22~45 parts of Camellia nitidissima, 21~33 parts of Radix Notoginseng and Radix Angelicae Sinensis to divide.
3. nourishing ovary health care tabletting according to claim 1 or 2, which is characterized in that in terms of mass fraction, the activity
Component includes 23 parts of 15 parts of pollen pini, 4 parts of ginseng, 31 parts of Camellia nitidissima, 27 parts of Radix Notoginseng and Radix Angelicae Sinensis.
4. nourishing ovary health care tabletting according to claim 3, which is characterized in that the auxiliary material includes honey, compressibility
Starch and sodium carboxymethyl starch.
5. a kind of Claims 1 to 4 any one of them nourish ovary health care tabletting preparation method its include the following steps：
The sundries in each raw material in the active component is rejected in pretreatment, featured, cleaning, drying, drying to moisture content
≤ 3% is spare；
Coarse crushing will be crushed with Roughpulverizer respectively by pretreated each raw material, and it is spare to cross 80~140 mesh sieve；
Each raw material after coarse crushing is obtained the micropowders of each raw material by ultramicro grinding through ultramicro grinding respectively；
Mixture granulation is uniform by the micropowders mixture of each raw material, and the auxiliary material is then added, and pelletized, dried successively,
Compressing tablet process, you can be made and nourish ovary health care tabletting.
6. the preparation method according to claim 5 for nourishing ovary health care tabletting, which is characterized in that the micropowders
Granularity is 800~900 mesh.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810396582.8A CN108703362A (en) | 2018-04-28 | 2018-04-28 | A kind of nourishing ovary health care tabletting and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810396582.8A CN108703362A (en) | 2018-04-28 | 2018-04-28 | A kind of nourishing ovary health care tabletting and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108703362A true CN108703362A (en) | 2018-10-26 |
Family
ID=63868636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810396582.8A Pending CN108703362A (en) | 2018-04-28 | 2018-04-28 | A kind of nourishing ovary health care tabletting and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108703362A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109770134A (en) * | 2019-03-26 | 2019-05-21 | 王军 | A kind of plant beverage of resisting ovarian failure and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1245068A (en) * | 1998-08-19 | 2000-02-23 | 汤振才 | Medicine for treating functional hemorrhage of uterus |
| CN1824198A (en) * | 2005-12-13 | 2006-08-30 | 王忠民 | Medicine for treating low function of ovary |
| CN103932189A (en) * | 2014-04-29 | 2014-07-23 | 云南省农业科学院高山经济植物研究所 | Special female health product |
| CN103961396A (en) * | 2014-05-23 | 2014-08-06 | 汤臣倍健股份有限公司 | Healthy soft capsule and preparation process thereof |
| CN106860680A (en) * | 2017-03-17 | 2017-06-20 | 广东说养自然医学技术有限公司 | Golden flower ginseng pressed candies and preparation method thereof |
-
2018
- 2018-04-28 CN CN201810396582.8A patent/CN108703362A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1245068A (en) * | 1998-08-19 | 2000-02-23 | 汤振才 | Medicine for treating functional hemorrhage of uterus |
| CN1824198A (en) * | 2005-12-13 | 2006-08-30 | 王忠民 | Medicine for treating low function of ovary |
| CN103932189A (en) * | 2014-04-29 | 2014-07-23 | 云南省农业科学院高山经济植物研究所 | Special female health product |
| CN103961396A (en) * | 2014-05-23 | 2014-08-06 | 汤臣倍健股份有限公司 | Healthy soft capsule and preparation process thereof |
| CN106860680A (en) * | 2017-03-17 | 2017-06-20 | 广东说养自然医学技术有限公司 | Golden flower ginseng pressed candies and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109770134A (en) * | 2019-03-26 | 2019-05-21 | 王军 | A kind of plant beverage of resisting ovarian failure and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103007234B (en) | Traditional Chinese medicine preparation for treating dysmenorrheal caused by endometriosis and preparation method of preparation | |
| CN104162094B (en) | A kind of Chinese medicine composition and its pharmaceutical preparation for treating Obesity-type Polycystic Ovary Syndrome | |
| CN103933224B (en) | A kind of Chinese medicine composition for treating gout | |
| CN100418562C (en) | Medicinal composition, its preparing method and quality controlling means | |
| CN110478452A (en) | A kind of Chinese medicine composition and preparation method thereof for treating gout | |
| CN105055855B (en) | With Chinese medicine composition for improving sleep, strengthen immunity effect and its preparation method and application | |
| CN106491972B (en) | One kind preventing antipodagric Chinese medicine composition and preparation method thereof | |
| CN102813870A (en) | Chinese herbal compound preparation used for treating alcoholism and gout and preparation method and application thereof | |
| CN108703362A (en) | A kind of nourishing ovary health care tabletting and preparation method thereof | |
| CN105833055A (en) | Traditional Chinese medicine composition for treating hypertension, hyperlipidemia and hyperglycemia and preparing method and application thereof | |
| CN104524096B (en) | A kind ofly treat Chinese medicine preparation of deficiency of the liver and kidney dysmenorrhea and preparation method thereof | |
| TW202009011A (en) | Composition for nourishing yin and tonifying kidney and preparation method and applications thereof | |
| CN109793826A (en) | A kind of Chinese medicine composition for treating fracture of children | |
| CN109663131A (en) | The composition of relax bowel and defecation | |
| CN107982511A (en) | A kind of Chinese medicine composition, its preparation method and application for treating primary dysmenorrhea | |
| CN103285110B (en) | Traditional Chinese medicine for treating hyperlipidemia and preparation method thereof | |
| CN105535466A (en) | Pharmaceutical composition for treating pubescent polycystic ovarian syndrome | |
| CN102793826B (en) | Traditional Chinese medicine for treating hypertension early-stage kidney damage and preparation method thereof | |
| CN106420891A (en) | Application of folium cortex eucommiae general flavone in preparation of medicine for treating perimenopausal syndrome | |
| CN105194676A (en) | Medicine composition for treating hyperlipemia and preparation method of medicine composition | |
| CN100594923C (en) | Oral administered medicinal composition and its preparation and usage | |
| CN105148120A (en) | Traditional Chinese medicine for effective prevention and cure of male hyperuricemia accompanied with gout | |
| CN104127512A (en) | Traditional Chinese medicine composition for treating obesity | |
| CN104623563A (en) | Traditional-Chinese-medicine preparation for postoperative rehabilitation of sigmoid colon cancer | |
| CN105770214A (en) | Traditional Chinese medicine preparation for treating ankle fracture and preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181026 |